New first and second generation inhibitors of human immunodeficiency virus-1 integrase

Author： Pendri Annapurna   Meanwell Nicholas A   Peese Kevin M   Walker Michael A  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.8, 2011-08, pp. : 1173-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Second Generation HIV-1 Integrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

By  

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3335-3342

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite

Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) Activity

By  

Current Pharmaceutical Design, Vol. 10, Iss. 21, 2004-08 ,pp. : 2643-2648

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1- Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview

By  

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1874-1898

Bentham Science Publishers

Access to resources Recommend Favorite